Receive our unique vitiligo formula, completely FREE of charge!

Longevity

Longevity Briefs: A Single Protein May Regulate Ageing In Multiple Organs

Posted on 14 October 2026

Getting your Trinity Audio player ready...

Longevity briefs provides a short summary of novel research in biology, medicine, or biotechnology that caught the attention of our researchers in Oxford, due to its potential to improve our health, wellbeing, and longevity.

The problem:

Inflammation is the body’s first line of defence against pathogens, helping to keep infection at bay until the slower but more efficient components of the immune system (including T and B cells) can mount a response that is ‘tailor-made’ to eliminate the specific pathogen in question. The downside of inflammation is that it causes a lot of collateral damage to human cells, which becomes a problem if inflammation lasts too long (chronic inflammation), or if it occurs in places where it should not. In older age, the immune system shifts towards a more inflammatory state, which results in low levels of constant inflammation throughout the body. This age-related chronic inflammation, known as inflammageing, quietly contributes to age-related diseases like dementia, cardiovascular diseases, cancer and more.

One potentially important link between inflammation and accelerated ageing involves a brain region called the hypothalamus, specifically a sub-region called the ventromedial hypothalamus (VMH). The hypothalamus is a vital control centre that regulates blood pressure, sleep rhythms and hormone levels alongside many other important roles. Previous research has suggested that rising inflammation within the VMH was associated with accelerated ageing in animals, so targeting inflammation within this part of the brain could be particularly efficient for slowing ageing. In this study, researchers show that restoring levels of a single protein is sufficient to reduce inflammation in the VMH of mice, resulting in wide ranging health benefits outside the brain.

The discovery:

The authors of this study had already conducted previous research showing that menin, a protein mainly found in the cell nucleus and which regulates gene activity, could suppress inflammation through a mechanism that is known to be particularly important in the hypothalamus. For this reason, researchers suspected that menin levels might play a role in age-related inflammation within the VMH. To test this, researchers first looked at ageing mice and found that menin levels in the hypothalamus declined much more rapidly than in other brain regions. Researchers then genetically engineered mice so that a population of neurons found only in the VMH would not be able to produce menin. Measurements related to ageing including inflammation, cognitive function and physical characteristics were then taken at various timepoints and compared to control mice whose neurons could still produce menin. The actual numbers of mice varied between experiments, but were as high as 24 controls and 17 modified mice in the behavioural tests and considerably smaller in some of the more demanding experiments.

Sure enough, inflammatory signalling in the VMH was significantly increased in the menin-deficient mice, but that wasn’t all. The deficient mice also showed signs of premature ageing including thinner skin, lower bone mass, reduced muscle fibre size and more cellular senescence (a state in which cells stop dividing and release inflammatory signals). Their memory and learning was also significantly worse than the control mice, and the control mice lived significantly longer on average. The median lifespan of the control mice (meaning the age by which half of the mice were dead) was around 150 days longer than those of the menin-deficient mice.

If menin deficiency caused accelerated ageing, could restoring menin production in aged mice achieve the reverse? The answer appeared to be yes: when researchers used gene therapy to restore menin production in the VMH regions of 20 month-old mice (roughly ‘equivalent’ to humans in their 60s), the 19 treated mice had thicker skin, more bone mass, and better cognitive performance than the 19 mice given a control treatment. Treated mice also lived significantly longer.

Survival over time for mice treated with menin gene therapy (bright red) and control mice (faded red).
Hypothalamic Menin regulates systemic aging and cognitive decline

Finally, researchers looked for chemical pathways that could be involved in the cognitive benefits of menin. They noted that declines in menin with age correlated with a decline in D-serine, an amino acid protein building block that is of particular importance in the brain. This is because D-serine is required for the function of NMDA receptors, a type of receptor that is deeply involved in learning and memory. Further investigation showed that menin was able to activate a gene that initiates D-serine production. Based on this evidence, researchers tried giving D-serine to eighteen mice that were genetically engineered to be menin-deficient. They found that D-serine was able to restore cognitive function to normal in these mice.

The implications:

This study suggests the possibility that menin may indirectly affect the pace of ageing in multiple organs, presumably by preventing inflammation in the hypothalamus. It also suggests that D-serine supplementation may counteract some of the negative effects of menin deficiency on cognition.

D-serine is available as a dietary supplement. However, it is important to note that this study only showed that D-serine improved cognitive function in mice genetically engineered to lack menin production in neurons of the VMH. If you create a problem and then provide a solution, of course you are likely to see some improvement. This doesn’t necessarily mean that humans with reduced menin levels as a result of natural ageing would benefit from D-serine. In fact, research in mice is not entirely clear on whether D-serine supplementation is beneficial, with some research even suggesting that elevated D-serine could contribute to early Alzheimer’s progression. There is therefore a lot more research to be done before D-serine supplementation can be recommended for general cognitive health.


Never Miss a Breakthrough!

Sign up for our newletter and get the latest breakthroughs direct to your inbox.

    References

    Hypothalamic Menin regulates systemic aging and cognitive decline https://doi.org/10.1371/journal.pbio.3002033

    Title image by Alexandar Todov, Unsplash

    Featured in This Post
    Topics

    Never Miss a Breakthrough!

    Sign up for our newletter and get the latest breakthroughs direct to your inbox.

      Copyright © Gowing Life Limited, 2026 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.